Keyphrases
Percutaneous Coronary Intervention
100%
Confidence Interval
79%
Acute Coronary Syndrome
68%
Myocardial Infarction
65%
Aspirin
58%
Clopidogrel
55%
Hazard Ratio
44%
Meta-analysis
40%
Heart Failure
40%
Cardiovascular Mortality
39%
Dual Antiplatelet Therapy
38%
ST-elevation Myocardial Infarction (STEMI)
35%
Coronary Artery Disease
35%
Get With The Guidelines
34%
Cardiovascular Outcomes
34%
Placebo
33%
Atrial Fibrillation
32%
Acute Myocardial Infarction
30%
Atherothrombosis
30%
Cardiovascular Risk
29%
Antiplatelet Therapy
29%
Peripheral Arterial Disease
29%
Odds Ratio
28%
Cardiovascular Events
28%
Type 2 Diabetes Mellitus (T2DM)
27%
Major Adverse Cardiovascular Events
27%
Randomized Trial
27%
High Risk
25%
Revascularization
25%
Bleeding
24%
Cardiovascular Disease
23%
All-cause Mortality
23%
Ischemic Events
23%
Cangrelor
23%
United States
22%
Clinical Outcomes
22%
Ticagrelor
22%
Diabetes
21%
Type 2 Diabetic Patients
21%
Randomized Clinical Trial
20%
In-hospital Mortality
20%
Secondary Prevention
20%
Hospitalization
20%
Acute Ischemic Stroke
19%
Icosapent Ethyl
18%
Risk Factors
17%
Statins
17%
Bleeding Risk
17%
Health Registries
17%
Ischemic Stroke
17%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
97%
Acetylsalicylic Acid
68%
Acute Coronary Syndrome
67%
Antiplatelet
63%
Congestive Heart Failure
62%
Cerebrovascular Accident
61%
Cardiovascular Disease
60%
Clopidogrel
57%
Bleeding
54%
Coronary Artery Disease
53%
Placebo
50%
Thrombosis
37%
Non Insulin Dependent Diabetes Mellitus
34%
Atrial Fibrillation
33%
Diseases
32%
Cardiovascular Risk
32%
Brain Ischemia
29%
Ticagrelor
25%
Acute Heart Infarction
25%
Peripheral Occlusive Artery Disease
24%
Randomized Controlled Trial
23%
Anticoagulant Agent
23%
Diabetes Mellitus
23%
Cangrelor
22%
All Cause Mortality
21%
Statin (Protein)
20%
Clinical Trial
20%
Randomized Clinical Trial
19%
ST Segment Elevation Myocardial Infarction
19%
Icosapentaenoic Acid Ethyl Ester
18%
Rivaroxaban
17%
Alirocumab
16%
Hospital Mortality
15%
Coronary Artery Atherosclerosis
14%
Antithrombotic Therapy
14%
Prevalence
13%
Stent Thrombosis
13%
Dapagliflozin
13%
Brain Hemorrhage
13%
Low Density Lipoprotein Cholesterol
12%
Chronic Kidney Failure
12%
Warfarin
12%
Fibrinogen Receptor
12%
Combination Therapy
12%
Antithrombocytic Agent
11%
Atherosclerosis
11%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Inflammation
10%
Adverse Event
10%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Medicine and Dentistry
Cardiovascular System
79%
Percutaneous Coronary Intervention
76%
Myocardial Infarction
60%
Apoplexy
53%
Congestive Heart Failure
50%
Antiplatelet
49%
Coronary Artery Disease
49%
Acute Coronary Syndrome
43%
Cardiovascular Disease
40%
Meta-Analysis
33%
Thrombosis
32%
Odds Ratio
31%
Hazard Ratio
29%
Revascularization
28%
Bleeding
27%
Brain Ischemia
27%
Cardiovascular Risk
26%
Atrial Fibrillation
25%
Acute Heart Infarction
25%
Diabetes
24%
Diseases
24%
Maturity Onset Diabetes of the Young
23%
ST Segment Elevation Myocardial Infarction
20%
Clinical Trial
18%
Placebo
18%
Acetylsalicylic Acid
18%
Randomized Controlled Trial
18%
Systematic Review
17%
Percutaneous Aortic Valve Replacement
17%
Diabetes Mellitus
17%
Arteriosclerosis Obliterans
16%
Hospital Mortality
16%
Clopidogrel
16%
Statin
15%
Drug-Eluting Stent
15%
Platelet
14%
Antithrombotic
14%
Combination Therapy
13%
Chronic Kidney Disease
13%
Outpatient
13%
Randomized Clinical Trial
13%
Blood Pressure
13%
Coronary Artery Bypass Graft
13%
Secondary Prevention
12%
Cangrelor
12%
Prevalence
12%
Health Care Cost
12%
Icosapentaenoic Acid Ethyl Ester
12%
Patient with Type 2 Diabetes
12%
Blood Clot Lysis
11%